Single-use Biomanufacturing Industry To Grow Substantially At A CAGR Of 16.60% During 2022 To 2030
Single-use Biomanufacturing Industry Data Book Covers Single-Use Bioprocessing, Bioreactor, Assemblies & Filtration Assemblies Markets.
Single-use
Bioprocessing Probes And Sensors Market Report Highlights
The global single-use bioprocessing probes and sensors market size
was valued at USD 19.36 billion in 2021, and it is expected to reach USD 5.4
billion by 2028. The market is expected to expand at a CAGR of 13.9% from 2021
to 2028.
·
Single-use pH and dissolved
oxygen sensors are the most used disposable sensors in the bioprocessing
industry. Products for pressure measurement have already become widely accepted
and adopted
·
In 2020, the pH sensor segment
accounted for the major revenue share as these sensors can be deployed in
nearly all the biological processes
·
Single-use Dissolved Oxygen
(DO) and pH sensors are being used in upstream applications, leading to the
large revenue share of the segment
·
Increasing application of
disposable bioreactors in upstream biopharmaceutical production has driven the
use of sensors in this segment
·
In addition, the availability
of various single-use systems for upstream bioprocessing further supplements
segment growth
·
Biopharmaceutical manufacturers
have emerged as the key end-user of this market
·
Increasing adoption of
single-use technologies by CMOs is one of the key drivers for the growth of the
biopharmaceutical manufacturer segment
·
Geographically, North America
dominated the market in 2020 owing to the presence of biopharmaceutical
clusters and proactiveness of operating end-users in adopting new technologies
·
Asia Pacific is expected to be
the fastest-growing market over the forecast period, owing to the expanding
biomanufacturing capabilities in Asian countries
·
The key players are engaged in
collaboration with therapy developers to support their product development
process
Single-use
Bioreactors Market Report Highlights
The global single-use bioreactors market size was valued at USD 2.73 billion in 2021, and it is
expected to reach USD 12.06 billion by 2030, registering a CAGR of 17.19% from
2023 to 2030.
·
By product, the single-use bioreactor systems segment
held the dominant share in 2022. The availability of disposable bioprocess bags
in different sizes for a variety of uses, including the storage of reagents,
buffers, sterile medium, sera, and cell cultures, is predicted to drive the
market's expansion
·
By type, the stirred tank bioreactors segment held a
larger market share in 2022, driven by the increasing adoption of stirred tank
SUBs from pilot scale to large scale manufacturing, which is anticipated to
boost the market growth in the forecast years
·
Based on the type of cell, the mammalian cells segment
held a larger share in 2022. The segment is being driven by the increasing
usage of single-use bioreactors for mammalian cell culture in several research
studies. This is another key factor expected to drive market growth
significantly in the coming years
·
By molecule type insights, the vaccines segment held a
larger share in 2022. This is due to the less expensive nature and availability
in smaller volumes. This allows manufacturers to test different cell lines as
well as growth conditions more quickly and at a lower cost to improve vaccine
manufacturing
·
By application insights, the research and development
(R&D)/process development segment held a larger share in 2022. Single-use
bioreactors are most commonly used in GMP production, process development, and
research. Furthermore, the growing adoption of single-use bioreactors in
process development is facilitating the market growth
·
By usage insights, the lab-scale production segment held
a larger share in 2022. Various types of waste creation and bioreactor
operations are included in controlled laboratory-scale studies before scaling
up. Due to such advantages offered by lab-scale bioreactors, the market is
expected to grow during the forecast period
·
By end-use insights, the CMOs & CROs segment held a
larger share in 2022. CMOs are constantly changing processing facilities as
well as lines, and the more stable product developers for bioprocessing
equipment & facilities. Thus, propelling the market growth
·
North America held the largest market share in 2022. The
North American market is predicted to be driven due to the presence of key
players and the well-established biopharmaceutical industry in the region
·
The major companies providing single-use bioreactor
products operating in the North American region include Danaher Corporation,
Thermo Fisher Scientific, and others, and the presence of a highly developed
healthcare research framework and substantial expenditure in R&D fuels the
market growth in the region
·
Asia Pacific is expected to expand at the highest rate in
the forecast period. Factors such as rising investments and funding initiatives
among Asian companies are expected to drive the market in the region.
Furthermore, China is expected to be at the forefront owing to the high
adoption of single-use technology in the country
Access the
Global Single-use Biomanufacturing Industry Data Book, 2022 to
2030, compiled with details like market sizing information & forecasts,
trade data, pricing intelligence, competition benchmarking, macro-environmental
analyses, and regulatory & technological framework studies
Single-use
Assemblies Market Report Highlights
The global single-use assemblies market size was valued at USD
8.37 billion in 2021, and it is expected to reach USD 39.96 billion by 2030,
registering a CAGR of 18.57% during the forecast period.
- The
filtration assemblies segment led the industry in 2021. Increased
regulatory prospects and the need to diminish the risk of contamination
have promoted the use of filtration assemblies for bulk and final fill
operations
- The bag
assemblies segment is expected to grow at a lucrative CAGR over the
forecast period. Advantages, such as no need for validation or cleaning,
lower shipping cost due to less weight, and low maintenance cost &
capital investment drive the segment growth
- The
filtration application segment held a larger revenue share in 2021.
Implementation of single-use assemblies for filtration is rapidly
increasing owing to benefits as it is time- & cost-effective and ready
to use, unlike the conventional filtration systems
- The
customized solutions segment captured the highest revenue share in 2021.
Several companies offer customized solutions to fast-track pharmaceutical
manufacturing and drug development
- The
pharmaceutical & biotechnological companies end-user segment led the
global industry in 2021. The growth of the current manufacturing
facilities for biopharmaceuticals drives the demand for single-use
assemblies
- The CROs
& CMOs segment is expected to grow at the fastest CAGR over the
forecast period. In recent years, CMOs have been integrating single-use
technology into most or all their bioprocess
- The quick
turnaround time and flexibility between process runs and various client
projects allowed by single-use equipment can enhance the CMO efficiency,
which aids in the reduction of the overall costs
Single-use
Filtration Assemblies Market Report Highlights
The global single-use filtration assemblies market size was estimated at USD 2.43 billion
in 2021, and it is expected to reach USD 7.0 billion by 2026 and is
projected to exhibit a CAGR of 11.2% during the forecast period.
·
Disposable membrane filtration captured the largest
revenue share, owing to its wide acceptance among biomanufacturers. Factors responsible
for this estimated share include high penetration of products and advantages
pertaining to efficiency and productivity
·
Centrifugation accounted for the lowest penetration owing
to the fact that commercial availability of single-use centrifuge was quite
delayed
·
Bioprocessing/biopharmaceuticals manufacturing
application dominated the single-use filtration assemblies market owing to high
adoption of this technology by contract biomanufacturers
·
Filters are estimated to account for the largest share owing
to their wide usage across all the end users
·
The U.S. bioprocessing sector is recognized as a leader
in single-use technology innovations, owing to increasing pipeline of
biopharmaceutical drugs from companies operating herein
·
On the other hand, Asia Pacific countries are expected to
serve as a lucrative source of revenue. This is primarily due to a constantly
developing healthcare sector in Asian countries, which in turn, has driven the
attention of global players. Presence of low-cost production facilities is
another crucial factor resulting in regional investments by global companies
·
Key participants include Sartorius AG; 3M Purification;
Danaher; Repligen Corporation; Merck Millipore; Cellab; Medela; Thermo Fisher
Scientific, Inc.; MEISSNER FILTRATION PRODUCTS, INC.; and DrM, Dr. Mueller AG.
Participants are involved in expansion of their portfolio to effectively serve
the growing demand for single-use filters among end users, particularly
biomanufacturers.
Order your
copy of the Free Sample of “Single-use Biomanufacturing
Industry Data Book - Single-Use Bioprocessing, Bioreactor, Assemblies &
Filtration Assemblies Market Size, Share, Trends Analysis, And Segment
Forecasts, 2022 - 2030” Data Book, published by Grand View Research
Competitive
Landscape
Key players operating in the single-use
biomanufacturing industry are –
·
Thermo Fisher
Scientific, Inc.
·
Sartorius AG; Corning, Inc.
·
Eppendorf AG; PBS Biotech, Inc.
·
Avantor, Inc.
·
Entegris, Inc.
·
Kuhner AG
·
MEISSNER FILTRATION PRODUCTS, INC.
·
Danaher Corporation
·
Merck KGaA.
·
Boehringer Ingelheim
·
Lonza
·
AGC Biologics (CMC Biologics)
·
Rentschler Biotechnologie GmbH.
Grand View Research’s Single-use
Biomanufacturing Industry data book is a collection of market sizing &
forecasts insights, market dynamics & trends, opportunity assessment,
regulatory & technology framework, pricing intelligence, competitive
benchmarking analyses, and macro-environmental analyses studies. Within the
purview of the data book, such information is systematically analyzed and
provided in the form of summary presentations and detailed outlook reports on
individual areas of research. The following data points will be included in the
final product offering in four reports and one sector report overview.
Go through the table of
content of Single-use Biomanufacturing Industry Data Book to get a
better understanding of the Coverage & Scope of the study
About Grand View Research
Grand View Research, U.S.-based market
research and consulting company, provides syndicated as well as customized
research reports and consulting services. Registered in California and
headquartered in San Francisco, the company comprises over 425 analysts and
consultants, adding more than 1200 market research reports to its vast database
each year. These reports offer in-depth analysis on 46 industries across 25
major countries worldwide. With the help of an interactive market intelligence
platform, Grand View Research helps Fortune 500 companies and renowned academic
institutes understand the global and regional business environment and gauge
the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: Micro
Markets
Comments
Post a Comment